4
Changes in Ownership
RenovoRx, Inc. Filed Acc 0001493152-26-024726
Chief Financial Officer bought 25,000 shares at $0.79 ($19,690)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| VOLL MARK Chief Financial Officer | 2026-05-19 | Purchase | +25,000 | $0.79 | $19,690 | 142,380 | D: show line 1 in the form |
| Open-market purchases · 25,000 sh · avg $0.79 · $19,690 | |||||||
Loading xslF345X06/ownership.xml…